IC-OPM · Registering as Listener

International Conference on Oncology and Personalized Medicine

📅 20–21 Oct 2026 📍 Edinburgh, UK 👤 Standard / Listener

Listener registration from

$259

virtual · $259 in person

Registration benefits
✉
Official invitation letterIssued automatically after registration
📜
Certificate & digital materialsCertificate, slides and resource materials
🌐
Supporting global researchConnect with researchers across 30+ countries

For Support Please Contact

helpdesk@apste.net

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessionsNetworkingCertificateInvitation letterConference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply

FAST10 applied for 10% off — press Apply to confirm.

I agree to the Terms & Conditions and Refund & Cancellation Policy.

VISAMastercardAmexPayPal

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Conference session tracks

Key research areas covered across the sessions — tap a track to read more.

This track will explore the latest developments in personalized oncology, focusing on tailored treatment strategies based on individual genetic profiles. Discussions will include case studies and innovative approaches to enhance patient outcomes.

This session will delve into the role of biomarkers in the early detection and management of cancer. Researchers will present findings on novel biomarkers that can predict treatment responses and disease progression.

This track will examine the evolving landscape of immunotherapy in oncology, highlighting recent breakthroughs and clinical applications. Participants will engage in discussions about the challenges and opportunities in harnessing the immune system to combat cancer.

This session will focus on the complex interactions within the tumor microenvironment and their implications for cancer progression and therapy. Presentations will cover cellular and molecular mechanisms that influence tumor behavior.

This track will address the implementation of precision medicine in oncology, discussing both the strategies employed and the challenges faced in clinical practice. Experts will share insights on integrating genomic data into treatment plans.

This session will highlight the importance of translational research in oncology, focusing on how laboratory discoveries can be effectively translated into clinical applications. Participants will discuss successful case studies and future directions.

This track will showcase cutting-edge treatment modalities in oncology, including novel chemotherapeutic agents and targeted therapies. Researchers will present their findings on efficacy and safety profiles of these innovative treatments.

This session will explore the role of genomic and epigenomic alterations in cancer development and progression. Presentations will focus on how these changes can inform therapeutic strategies and patient management.

This track will address the unique challenges faced in pediatric oncology, including the need for tailored treatment approaches for younger patients. Discussions will include recent advancements and ongoing research in this critical area.

This session will examine the disparities in cancer care and outcomes across different populations. Researchers will present data and strategies aimed at addressing these inequities to improve access and treatment for all patients.

This track will provide a platform for discussing emerging trends and future directions in cancer research. Experts will share their visions for the next decade in oncology, including potential breakthroughs and areas of focus.